A detailed history of Ifm Investors Pty LTD transactions in Dexcom Inc stock. As of the latest transaction made, Ifm Investors Pty LTD holds 80,794 shares of DXCM stock, worth $6.16 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
80,794
Previous 80,379 0.52%
Holding current value
$6.16 Million
Previous $9.11 Million 40.59%
% of portfolio
0.05%
Previous 0.09%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$64.0 - $116.06 $26,560 - $48,164
415 Added 0.52%
80,794 $5.41 Million
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $76,775 - $97,753
696 Added 0.87%
80,379 $9.11 Million
Q1 2024

Apr 22, 2024

SELL
$114.22 - $140.1 $102,912 - $126,230
-901 Reduced 1.12%
79,683 $11.1 Million
Q4 2023

Jan 12, 2024

SELL
$75.49 - $124.16 $58,429 - $96,099
-774 Reduced 0.95%
80,584 $10 Million
Q3 2023

Oct 26, 2023

BUY
$86.06 - $137.93 $253,274 - $405,927
2,943 Added 3.75%
81,358 $7.59 Million
Q2 2023

Jul 27, 2023

BUY
$112.47 - $130.98 $575,284 - $669,962
5,115 Added 6.98%
78,415 $10.1 Million
Q1 2023

May 11, 2023

BUY
$104.0 - $122.92 $112,944 - $133,491
1,086 Added 1.5%
73,300 $8.52 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $389,888 - $562,809
4,588 Added 6.78%
72,214 $8.18 Million
Q3 2022

Oct 12, 2022

BUY
$76.35 - $94.18 $163,541 - $201,733
2,142 Added 3.27%
67,626 $5.45 Million
Q2 2022

Jul 15, 2022

BUY
$67.99 - $132.89 $3.37 Million - $6.59 Million
49,627 Added 312.97%
65,484 $4.88 Million
Q1 2022

Apr 13, 2022

BUY
$94.08 - $130.2 $306,324 - $423,931
3,256 Added 25.84%
15,857 $8.11 Million
Q4 2021

Jan 18, 2022

SELL
$129.87 - $162.82 $12,467 - $15,630
-96 Reduced 0.76%
12,601 $6.77 Million
Q3 2021

Oct 13, 2021

BUY
$106.71 - $143.18 $9,924 - $13,315
93 Added 0.74%
12,697 $6.94 Million
Q2 2021

Jul 16, 2021

BUY
$80.99 - $107.93 $167,649 - $223,415
2,070 Added 19.65%
12,604 $5.38 Million
Q1 2021

May 05, 2021

BUY
$84.79 - $104.74 $127,863 - $157,947
1,508 Added 16.71%
10,534 $3.79 Million
Q4 2020

Jan 13, 2021

BUY
$78.0 - $104.5 $112,320 - $150,480
1,440 Added 18.98%
9,026 $3.34 Million
Q3 2020

Oct 16, 2020

BUY
$95.51 - $112.95 $79,368 - $93,861
831 Added 12.3%
7,586 $3.13 Million
Q2 2020

Jul 13, 2020

SELL
$62.68 - $105.34 $165,099 - $277,465
-2,634 Reduced 28.05%
6,755 $2.74 Million
Q1 2020

Apr 09, 2020

SELL
$47.79 - $75.63 $17,491 - $27,680
-366 Reduced 3.75%
9,389 $2.61 Million
Q4 2019

Jan 13, 2020

BUY
$36.62 - $57.29 $19,042 - $29,790
520 Added 5.63%
9,755 $2.13 Million
Q3 2019

Nov 01, 2019

BUY
$35.53 - $43.8 $104,067 - $128,290
2,929 Added 46.45%
9,235 $1.38 Million
Q2 2019

Jul 16, 2019

BUY
$27.84 - $38.92 $33,686 - $47,093
1,210 Added 23.74%
6,306 $945,000
Q4 2018

Jan 23, 2019

BUY
$26.99 - $37.37 $137,541 - $190,437
5,096 New
5,096 $611,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Ifm Investors Pty LTD Portfolio

Follow Ifm Investors Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ifm Investors Pty LTD with notifications on news.